Functional relaxation as complementary therapy in irritable bowel syndrome: A randomized, controlled clinical trial

Journal of Alternative and Complementary Medicine

Volumn 16, Issue 1, 2010, Pages 47-52

  Lahmann, Claas ^a,b   Röhricht, Frank ^c   Sauer, Nina ^d   Noll Hussong, Michael ^a   Ronel, Joram ^a   Henrich, Gerhard ^a   Von Arnim, Angela ^e   Loew, Thomas ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e Department of Child and Adolescent Psychiatry Psychosomatic Medicine and Psychotherapy   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALTERNATIVE MEDICINE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; EMOTION; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; RELAXATION TRAINING; TREATMENT OUTCOME;

ADULT; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; RELAXATION THERAPY; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 76449094703     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2009.0084     Document Type: Article

References (31)

1. Spiller R, Aziz Q, Creed F, et al. Guidelines on the irritable bowel syndrome: Mechanisms and practical management. Gut 2007;56:1770-1798.
2. Andrews EB, Eaton SC, Hollis KA, et al. Prevalence and demographics of irritable bowel syndrome: Results from a large web-based survey. Aliment Pharmacol Ther 2005;22: 935-942.
3. Dean BB, Aguilar D, Barghout V, et al. Impairment in work productivity and health-related quality of life in patients with IBS. Am J Manag Care 2005;11:S17-S26.
4. Longstreth GF, Bolus R, Naliboff B, et al. Impact of irritable bowel syndrome on patients' lives: Development and psychometric documentation of a disease specificmeasure for use in clinical trials. Eur J Gastroenterol Hepatol 2005;17:411-420.
5. Chang L. Epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther 2004;20: 31-39.
6. Donker GA, Foets M, Spreeuwenberg P. Patients with irritable bowel syndrome: Health status and use of health care services. Br J Gen Pract 1999;49:787-792.
7. Icks A, Haastert B, Enck P, et al. Prevalence of functional bowel disorders and related health care seeking: A population- based study. Z Gastroenterol 2002;40:177-183.
8. Camilleri M. Treating irritable bowel syndrome: Overview, perspective and future therapies. Br J Pharmacol 2004;141: 1237-1248.
9. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications? Gastroenterology 2002;122:1140-1156.
10. Sykes MA, Blanchard EB, Lackner J, et al. Psychopathology in irritable bowel syndrome: Support for a psychophysiological model. J Behav Med 2003;26:361-372.
11. Spiller R, Bennett A. Searching for the answer to irritable bowel syndrome in the colonic mucosa: SERTainty and un- SERTainty. Gastroenterology 2007;132:437-441.
12. Coffin B, Bouhassira D, Sabate JM, et al. Alteration of the spinal modulation of nociceptive processing in patients with irritable bowel syndrome. Gut 2004;53:1465-1470.
13. Dunlop SP, Coleman NS, Blackshaw E, et al. Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol 2005;3:349-357.
14. Agrawal A, Whorwell PJ. Irritable bowel syndrome: Diagnosis and management. BMJ 2006;332:280-283.
15. Creed F, Fernandes L, Guthrie E, et al.; North of England IBS Research Group. The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology 2003;124:303-317. (Pubitemid 36169247)
16. Drossman DA, Toner BB, Whitehead WE, et al. Cognitivebehavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology 2003;125:19-31.
17. Svedlund J, Sjodin I, Ottosson JO, Dotevall G. Controlled study of psychotherapy in irritable bowel syndrome. Lancet 1983;2:589-592.
18. Webb AN, Kukuruzovic RH, Catto-Smith AG, Sawyer SM. Hypnotherapy for treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2007;4:CD005110.
19. Van der Veek P, van Rood Y, Masclee A. Clinical trial: Short- and long-term benefit of relaxation training for irritable bowel syndrome. Aliment Pharmacol Ther 2007;26: 943-952.
20. Blanchard EB, Greene B, Scharff L, Schwarz-McMorris SP. Relaxation training as a treatment for irritable bowel syndrome. Biofeedback Self Regul 1993;18:125-132.
21. Boyce PM, Talley NJ, Balaam B, et al. A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome. Am J Gastroenterol 2003;98:2209-2218.
22. Eriksson EM, Mö ller IE, Söderberg RH, et al. Body awareness therapy: A new strategy for relief of symptoms in irritable bowel syndrome patients. World J Gastroenterol 2007; 13:3206-3214.
23. Loew TH, Sohn R, Martus P, et al. Functional relaxation as a somatopsychotherapeutic intervention: A prospective controlled study. Altern Ther Health Med 2000;6:70-75.
24. Lahmann C, Loew TH, Tritt K, Nickel M. Efficacy of functional relaxation and patient education in the treatment of somatoform heart disorders: A randomized, controlled, clinical investigation. Psychosomatics 2008;49:378-385.
25. Loew TH, Tritt K, Siegfried W, et al. Efficacy of "functional relaxation" in comparison to terbutaline and a "placebo relaxation" method in patients with acute asthma: A randomized, prospective, placebo-controlled, crossover experimental investigation. Psychother Psychosom 2001;70:151-157.
26. Lahmann C, Nickel M, Schuster T, et al. Functional relaxation and guided imagery as complementary therapy in asthma: A randomized, controlled clinical trial. Psychother Psychosom 2009;78:233-239.
27. Drossman DA, Corazziari E, Talley NJ, et al. The Functional Gastrointestinal Disorders. Diagnosis, Pathophysiology and Treatment: A Multinational Consensus, 2nd ed. McLean, VA: Degnon Associates, 2000.
28. Lahmann C, Schoen R, Henningsen P, et al. Brief relaxation in comparison to music distraction in the treatment of dental anxiety: A randomized, controlled, clinical investigation. J Am Dent Assoc 2008;139:317-324.
29. Schepank H. Impairment Severity Score [in German]. Gö ttingen: Beltz, 1995.
30. Franz M, Tress W, Schepank H. Predicting extreme patterns of long-term course of psychogenic impairment: A tenyear- follow-up. Soc Psychiatry Psychiatr Epidemiol 1998;33: 243-251.
31. Arnim A. Functional relaxation: Psychotherapeutic tutorial. Fund Psychiatr 1994;8:196-203.